Kim, H.; Shin, K.; An, H.J.; Kim, I.-H.; Bae, J.H.; Lee, Y.S.; Lee, I.K.; Lee, M.; Park, S.J.
Real-World Comparison of Trifluridine–Tipiracil with or Without Bevacizumab in Patients with Refractory Metastatic Colorectal Cancer. Biomedicines 2025, 13, 976.
https://doi.org/10.3390/biomedicines13040976
AMA Style
Kim H, Shin K, An HJ, Kim I-H, Bae JH, Lee YS, Lee IK, Lee M, Park SJ.
Real-World Comparison of Trifluridine–Tipiracil with or Without Bevacizumab in Patients with Refractory Metastatic Colorectal Cancer. Biomedicines. 2025; 13(4):976.
https://doi.org/10.3390/biomedicines13040976
Chicago/Turabian Style
Kim, Hyunho, Kabsoo Shin, Ho Jung An, In-Ho Kim, Jung Hoon Bae, Yoon Suk Lee, In Kyu Lee, MyungAh Lee, and Se Jun Park.
2025. "Real-World Comparison of Trifluridine–Tipiracil with or Without Bevacizumab in Patients with Refractory Metastatic Colorectal Cancer" Biomedicines 13, no. 4: 976.
https://doi.org/10.3390/biomedicines13040976
APA Style
Kim, H., Shin, K., An, H. J., Kim, I.-H., Bae, J. H., Lee, Y. S., Lee, I. K., Lee, M., & Park, S. J.
(2025). Real-World Comparison of Trifluridine–Tipiracil with or Without Bevacizumab in Patients with Refractory Metastatic Colorectal Cancer. Biomedicines, 13(4), 976.
https://doi.org/10.3390/biomedicines13040976
